Renal denervation (RDN) has been shown as a safe and effective additive therapy to control blood pressure (BP) with or without background medication. The goal of this learning activity is to provide doctors with a comprehensive review of the latest findings from clinical trials and a global registry pertaining to RDN’s role in improving BP control among patients with uncontrolled hypertension (HTN).
Upon completing this module, participants will have a better understanding of the following aspects:
Treatment options for uncontrolled HTN
Latest data from clinical trials and a global registry showing the efficacy and safety of
RDN in managing uncontrolled HTN
Patient selection for optimal results
CPD Reviewer:
Professor Datin Dr Chia Yook Chin
Head of the Department of Medical Sciences,
Sunway University
Honorary Professor,
Department of Primary Care Medicine,
University of Malaya
Who should participate:
Doctors
NOTE:
Please read thoroughly & understand the module before attempting the assessment questions.
Terms & Conditions:
Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.
MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points.
The modules/articles are best viewed with: Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards-compliant browser may be required to view the modules.